Literature DB >> 16103249

The transition from hypertrophy to failure: how certain are we?

Mark H Drazner.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16103249     DOI: 10.1161/CIRCULATIONAHA.105.558734

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

Review 1.  Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?

Authors:  Sandeep Kamath; David Markham; Mark H Drazner
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

Review 2.  Treatment strategies for the prevention of heart failure.

Authors:  Justin L Grodin; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 3.  Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.

Authors:  Gabriele G Schiattarella; Joseph A Hill
Journal:  Circulation       Date:  2015-04-21       Impact factor: 29.690

4.  Reversibility of adverse, calcineurin-dependent cardiac remodeling.

Authors:  Jeff M Berry; Vien Le; David Rotter; Pavan K Battiprolu; Bennett Grinsfelder; Paul Tannous; Jana S Burchfield; Michael Czubryt; Johannes Backs; Eric N Olson; Beverly A Rothermel; Joseph A Hill
Journal:  Circ Res       Date:  2011-06-23       Impact factor: 17.367

5.  Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up.

Authors:  Ravi V Desai; Mustafa I Ahmed; Marjan Mujib; Inmaculada B Aban; Michael R Zile; Ali Ahmed
Journal:  Am J Cardiol       Date:  2010-12-02       Impact factor: 2.778

6.  Contractility evaluation by 2 dimensional echocardiography and gated SPECT myocardial perfusion scintigraphy in hypertensive patients with clinical presentation of atypical chest pain.

Authors:  H Yalçin; B Karayalçin; A Boz; B Talay; A Belgi; F Yalçin
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 7.  Diastolic and systolic heart failure: different stages or distinct phenotypes of the heart failure syndrome?

Authors:  Jean G F Bronzwaer; Walter J Paulus
Journal:  Curr Heart Fail Rep       Date:  2009-12

8.  Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients.

Authors:  Sudhir S Kushwaha; Eugenia Raichlin; Yuri Sheinin; Walter K Kremers; Krishnaswamy Chandrasekaran; Gregory J Brunn; Jeffrey L Platt
Journal:  Eur Heart J       Date:  2008-09-11       Impact factor: 29.983

9.  Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats.

Authors:  Tomoyoshi Koyanagi; Lily Y Wong; Koichi Inagaki; Olga V Petrauskene; Daria Mochly-Rosen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

10.  Characterisation of heart failure with normal ejection fraction in a tertiary hospital in Nigeria.

Authors:  Adedeji K Adebayo; Adewole A Adebiyi; Olulola O Oladapo; Okechukwu S Ogah; Akinyemi Aje; Dike B Ojji; Ayodele O Falase
Journal:  BMC Cardiovasc Disord       Date:  2009-11-18       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.